FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment

Later circadian timing of food intake is associated with increased body mass index Infomedix International

Weight gain and obesity has been described as an epidemic and a complex problem in the United States. Previous research has linked poor diet to weight gain and high body...

Read More
FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment MedEdge MEA

INDIANAPOLIS: Eli Lilly and Company’s (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide) injection, has received the green light from the U.S. Food and Dru...

Read More
Menu
Categories
How does it work